THYROGEN

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug THYROGEN contains one active pharmaceutical ingredient (API):

1 Thyrotropin alfa UNII AVX3D5A4LM - THYROTROPIN ALFA

Thyrotropin alfa (recombinant human thyroid stimulating hormone) is a heterodimeric glycoprotein produced by recombinant DNA technology. Binding of thyrotropin alfa to TSH receptors on thyroid epithelial cells stimulates iodine uptake and organification, and synthesis and release of thyroglobulin, triiodothyronine (T3) and thyroxine (T4). Read about Thyrotropin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
THYROGEN Powder for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01AB01	Thyrotropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AB Thyrotropin
Discover more medicines within H01AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2700D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502818100078117, 576720020055217
Country: CA	Health Products and Food Branch	Identifier(s): 02246016
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 134-MBE-0419
Country: EE	Ravimiamet	Identifier(s): 1196805, 1196816
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 99122002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 467696
Country: FR	Base de données publique des médicaments	Identifier(s): 68937442
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 95276
Country: HK	Department of Health Drug Office	Identifier(s): 54932
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4197
Country: IT	Agenzia del Farmaco	Identifier(s): 034716011, 034716023
Country: JP	医薬品医療機器総合機構	Identifier(s): 7990403E1025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031290, 1031291
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100126525
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W42160001, W42160002
Country: SG	Health Sciences Authority	Identifier(s): 13164P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809799196
Country: US	FDA, National Drug Code	Identifier(s): 58468-0030
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/21.3/0869